|Bid||59.53 x 900|
|Ask||59.56 x 1300|
|Day's range||59.36 - 59.68|
|52-week range||15.00 - 63.73|
|Beta (3Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||62.13|
Alcon, the global leader in eye care, will launch DAILIES® COLORS contact lenses at the 2019 Optometry’s Meeting, as well as give attendees a preview of PRECISION1™ contact lenses coming soon to the US. The meeting is taking place June 19-23 at the America’s Center Convention Complex (ACCC) in St. Louis, Missouri.
Alcon, the global leader in eye care, is teaming up with gold- and silver-medal winning gymnast Laurie Hernandez on a new campaign that encourages people to find inspiration to visualize and achieve their goals. The “Eye Can, Eye Will” campaign is based on Laurie’s belief that personal mantras and clear, comfortable vision with DAILIES TOTAL1® contact lenses have helped her maintain the focus and enthusiasm needed to get to the top of her game. This campaign is rolling out during a pivotal time for Laurie, as she prepares to compete in next year’s games in Tokyo.
Algoma Shipping Ltd. (“Algoma” or “the Company”), a subsidiary of Algoma Central Corporation (TSX:ALC), and a leading provider of marine transportation services, today announced that the acquisition of the interest held by Oldendorff Carriers GMBH & Co. (Oldendorff) in the CSL International Pool (the Pool) including the three vessels owned by Oldendorff operating in the Pool has been finalised. The handy-sized Algoma Verity (formerly the Alice Oldendorff) and the panamax sized Algoma Valour and Algoma Victory (formerly the Harmen Oldendorff and the Sophie Oldendorff, respectively) bring Algoma’s ocean going self-unloader fleet to eight vessels operating in the Pool. The Company currently manages over 30 vessels from offices in St. Catharines, Ontario and Fort Lauderdale, Florida, leveraging its experienced staff with substantial technical and engineering expertise.
GENEVA-- -- First quarter sales of $1.8 billion, flat to last year; an increase of 4% constant currency Healthy momentum in Surgical business, with 2% growth and 7% constant currency growth Full year 2019 outlook of 3% to 5% constant currency net sales growth and 17% to 18% core operating margin Regulatory News: Alcon , the global leader in eye care, today reported selected financial results for the ...
GENEVA-- -- Large scientific program will reinforce the ongoing clinical and patient benefits of its robust portfolio Highlights include new product launches in phacoemulsification, visualization for the Cataract Refractive Suite and innovations in intraoperative aberrometry and AT-IOLs Onsite events for surgeons demonstrate Alcon’s continued commitment to world-class training, education Alcon, the ...
Health-care earnings begin in earnest this week. Centene Corp. reported on Tuesday, and Anthem Inc., Biogen Inc., Boston Scientific Corp. and Novartis AG are set to report Wednesday.
Alcon (ALC.SW) (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today that it will provide a trading update and host a conference call on Thursday, May 16, at 3:00 p.m. Central European Time / 8 a.m. Central Time for the quarter ended March 31, 2019. This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Alcon. This publication may contain certain forward-looking statements concerning the Company and its business.
Newly spun off from Novartis, the eye-care giant has strong growth potential and is better off as an independent company.
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its debut as an independent, publicly traded company and the completion of its separation from Novartis.